ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Taurean7
|
71 |
18K |
7 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
71
|
18K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Taurean7
|
194 |
72K |
15 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
194
|
72K
|
15
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Taurean7
|
1.5K |
562K |
7 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
1.5K
|
562K
|
7
|
|
Charts
|
XRF |
Re:
XRF Charts
|
|
Taurean7
|
43 |
22K |
5 |
28/04/24 |
28/04/24 |
Charts
|
43
|
22K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Taurean7
|
194 |
72K |
37 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
194
|
72K
|
37
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Taurean7
|
1.5K |
562K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.5K
|
562K
|
8
|
|
ASX - By Stock
|
A4N |
Re:
A4N versus QPM and CCM
|
|
Taurean7
|
18 |
6.0K |
7 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
18
|
6.0K
|
7
|
|
ASX - By Stock
|
A4N |
Re:
Ann: Projects Update
|
|
Taurean7
|
74 |
24K |
15 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
74
|
24K
|
15
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Pharmaceuticals - Business Update
|
|
Taurean7
|
22 |
7.7K |
12 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
22
|
7.7K
|
12
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
Taurean7
|
986 |
333K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
986
|
333K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
Taurean7
|
39 |
8.3K |
6 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
8.3K
|
6
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Change of Director's Interest Notice
|
|
Taurean7
|
178 |
51K |
20 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
178
|
51K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
Taurean7
|
130 |
62K |
44 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
130
|
62K
|
44
|
|
ASX - By Stock
|
DUG |
Re:
Share Price Discussion
|
|
Taurean7
|
55 |
26K |
3 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
55
|
26K
|
3
|
|
ASX - By Stock
|
SLX |
Re:
Chart
|
|
Taurean7
|
372 |
117K |
16 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
372
|
117K
|
16
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
Taurean7
|
1.6K |
829K |
25 |
17/02/24 |
17/02/24 |
Charts
|
1.6K
|
829K
|
25
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Taurean7
|
347 |
103K |
28 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
347
|
103K
|
28
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Nuclear Medicine: From Concept to Clinic and Commercialization (CB chapter in Pr. Richard Baum tribute book)
|
|
Taurean7
|
17 |
8.4K |
5 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
17
|
8.4K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
Taurean7
|
40 |
19K |
20 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
40
|
19K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
Taurean7
|
40 |
19K |
31 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
40
|
19K
|
31
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Taurean7
|
1.5K |
562K |
27 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
1.5K
|
562K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
Taurean7
|
40 |
19K |
11 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
40
|
19K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
Taurean7
|
40 |
19K |
7 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
40
|
19K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Forecasts 2024
|
|
Taurean7
|
40 |
19K |
7 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
40
|
19K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
|
|
Taurean7
|
32 |
10K |
20 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
32
|
10K
|
20
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
Taurean7
|
1.6K |
829K |
32 |
20/11/23 |
20/11/23 |
Charts
|
1.6K
|
829K
|
32
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Taurean7
|
1.5K |
562K |
9 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
1.5K
|
562K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Taurean7
|
9.9K |
4.4M |
52 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
52
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Taurean7
|
66 |
15K |
8 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
66
|
15K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Taurean7
|
9.9K |
4.4M |
14 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Taurean7
|
9.9K |
4.4M |
13 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
13
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Taurean7
|
124 |
40K |
8 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
124
|
40K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Taurean7
|
124 |
40K |
18 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
124
|
40K
|
18
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Taurean7
|
45 |
13K |
10 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
45
|
13K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
NSW Supreme Court decisions on Resapp (Pfizer S of A)
|
|
Taurean7
|
18 |
20K |
1 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
18
|
20K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Taurean7
|
1.5K |
562K |
28 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
1.5K
|
562K
|
28
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Change of Director's Interest Notice
|
|
Taurean7
|
28 |
8.1K |
4 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
28
|
8.1K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Urology Innovation Showcase
|
|
Taurean7
|
58 |
22K |
2 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
58
|
22K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Taurean7
|
1.5K |
562K |
9 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
1.5K
|
562K
|
9
|
|
ASX - By Stock
|
RED |
Re:
Ann: King of the Hills on track for commercial production
|
|
Taurean7
|
112 |
49K |
3 |
04/12/22 |
04/12/22 |
ASX - By Stock
|
112
|
49K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Pharmargeddon
|
|
Taurean7
|
11 |
3.8K |
6 |
06/11/22 |
06/11/22 |
ASX - By Stock
|
11
|
3.8K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
NSW Supreme Court decisions on Resapp (Pfizer S of A)
|
|
Taurean7
|
18 |
20K |
22 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
18
|
20K
|
22
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Expansion and Acceleration of Clinical Programs
|
|
Taurean7
|
70 |
26K |
19 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
70
|
26K
|
19
|
|
ASX - By Stock
|
AN1 |
Re:
Roquefort/Lyramid postings
|
|
Taurean7
|
186 |
43K |
9 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
186
|
43K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Notification of cessation of securities - RAP
|
|
Taurean7
|
29 |
14K |
12 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
29
|
14K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Ceasing to be a substantial holder
|
|
Taurean7
|
20 |
9.0K |
7 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
20
|
9.0K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Scheme Meeting
|
|
Taurean7
|
250 |
79K |
9 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
250
|
79K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Scheme Meeting
|
|
Taurean7
|
250 |
79K |
15 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
250
|
79K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Scheme Meeting
|
|
Taurean7
|
250 |
79K |
21 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
250
|
79K
|
21
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Appoints Dr John Prendergast as Executive Chairman
|
|
Taurean7
|
8 |
4.1K |
10 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
8
|
4.1K
|
10
|
|